Related Experiment Video
Updated: Sep 27, 2026

Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes
Published on: June 25, 2017
Glucose-regulated glucose uptake by transplanted muscle cells expressing glucokinase counteracts diabetic
Pedro J Otaegui1, Maria Ontiveros, Tura Ferre
1Department of Biochemistry and Molecular Biology, School of Veterinary Medicine, and Center of Animal Biotechnology and Gene Therapy, Universitat Autònoma de Barcelona, E-08193 Bellaterra, Spain.
Abstract:
Type 1 diabetic patients depend on insulin replacement therapy. However, chronic hyperglycemia due to failure to maintain proper glycemic control leads to microvascular, macrovascular, and neurological complications. Increased glucose disposal by tissues engineered to overexpress key regulatory genes in glucose transport or phosphorylation can reduce diabetic hyperglycemia. Here we report that differentiated myoblast cells expressing the glucose-phosphorylating enzyme glucokinase (GK) showed a glucose-dependent increase in glucose uptake and utilization in vitro. Transplantation of GK-expressing myotubes into healthy mice did not alter blood glucose levels and recipient mice maintained normoglycemia. After streptozotocin treatment, mice transplanted with GK-expressing myotubes counteracted hyperglycemia, polydipsia, and polyphagia, whereas mice transplanted with control myotubes developed diabetes. Similarly, diabetic mice transplanted with control myotubes remained hyperglycemic. In contrast, transplantation of GK-expressing myotubes into diabetic mice lowered hyperglycemia. These results suggest that the use of genetically engineered muscle cells to express glucokinase may provide a glucose-regulated approach to reduce diabetic hyperglycemia.
Insights
Genetically engineered muscle cells expressing glucokinase (GK) can help manage type 1 diabetes. Transplanted GK-expressing myotubes effectively lowered hyperglycemia in diabetic mice, offering a potential glucose-regulated therapy.
Area of Science:
- Biotechnology
- Metabolic Diseases
- Gene Therapy
Background:
- Type 1 diabetes management relies on insulin therapy, but chronic hyperglycemia causes severe complications.
- Effective glycemic control is crucial for preventing microvascular, macrovascular, and neurological damage in diabetic patients.
- Engineering tissues to enhance glucose disposal offers a novel therapeutic strategy for hyperglycemia.
Purpose of the Study:
- To investigate the potential of genetically engineered muscle cells expressing glucokinase (GK) as a glucose-regulated therapy for diabetic hyperglycemia.
- To assess the in vitro glucose uptake and utilization of GK-expressing myoblasts.
- To evaluate the in vivo efficacy of GK-expressing myotube transplantation in ameliorating hyperglycemia in mouse models of diabetes.
Main Methods:
- Differentiated myoblast cells were engineered to overexpress the glucokinase (GK) enzyme.
- In vitro studies assessed glucose uptake and utilization in GK-expressing myoblasts.
- GK-expressing myotubes and control myotubes were transplanted into healthy and streptozotocin-induced diabetic mice.
- Blood glucose levels, polydipsia, and polyphagia were monitored post-transplantation.
Main Results:
- GK-expressing myoblasts demonstrated increased glucose uptake and utilization in a glucose-dependent manner in vitro.
- Transplantation of GK-expressing myotubes into diabetic mice significantly lowered hyperglycemia, polydipsia, and polyphagia.
- Control myotube transplants did not improve glycemic control in diabetic mice.
- Transplantation into healthy mice did not disrupt normoglycemia.
Conclusions:
- Genetically engineered muscle cells expressing glucokinase hold promise for a glucose-regulated therapeutic approach to manage diabetic hyperglycemia.
- This strategy offers a potential alternative or adjunct to traditional insulin therapy for type 1 diabetes.
- Further research into the long-term efficacy and safety of GK-expressing myotube transplantation is warranted.
More Related Videos
Related Concept Videos
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Hypoglycemia and Glucagon
Insulin: The Receptor and Signaling Pathways
Cell Specific Gene Expression

